Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2017, Article ID 9463272, 7 pages
https://doi.org/10.1155/2017/9463272
Research Article

The Impact of tagSNPs in CXCL16 Gene on the Risk of Myocardial Infarction in a Chinese Han Population

1Institute of Aging Research, Guangdong Medical University, Dongguan, China
2Guangdong Provincial Key Laboratory of Medical Molecular Diagnostics, Guangdong Medical University, Dongguan, China
3Institute of Biochemistry & Molecular Biology, Guangdong Medical University, Zhanjiang, China
4Department of Clinical Laboratory, The Affiliated Hospital of Guangdong Medical University, Zhanjiang, China
5Department of Cardiovascular Disease, The First People’s Hospital of Foshan, Foshan, China
6Department of Cardiovascular Disease, The Affiliated Hospital of Guangdong Medical University, Zhanjiang, China

Correspondence should be addressed to Xinguang Liu; moc.621@46uilgx and Xing-dong Xiong; moc.621@gnodgnixgnoix

Received 13 September 2016; Revised 25 December 2016; Accepted 22 January 2017; Published 14 February 2017

Academic Editor: Michele Malaguarnera

Copyright © 2017 Shun Xu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. X.-H. Zhang, Z. L. Lu, and L. Liu, “Coronary heart disease in China,” Heart, vol. 94, no. 9, pp. 1126–1131, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. R. Ramaraj, “Risk factors for myocardial infarction in women and men,” European Heart Journal, vol. 30, no. 8, pp. 1012–1013, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Xu, J. Cheng, Y.-N. Chen et al., “The LRP6 rs2302685 polymorphism is associated with increased risk of myocardial infarction,” Lipids in Health and Disease, vol. 13, no. 1, article 94, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. Z. Juan, Z. Wei-Guo, S. Heng-Liang, and W. Da-Guo, “Association of matrix metalloproteinase 9 C-1562T polymorphism with genetic susceptibility to myocardial infarction: a meta-analysis,” Current Therapeutic Research - Clinical and Experimental, vol. 77, pp. 40–45, 2015. View at Publisher · View at Google Scholar · View at Scopus
  5. A. E. Norlander, M. A. Saleh, and M. S. Madhur, “CXCL16: a chemokine-causing chronic kidney disease,” Hypertension, vol. 62, no. 6, pp. 1008–1010, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. A. M. Jansson, P. Aukrust, T. Ueland et al., “Soluble CXCL16 predicts long-term mortality in acute coronary syndromes,” Circulation, vol. 119, no. 25, pp. 3181–3188, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. P. Seizer, K. Stellos, G. Selhorst et al., “CXCL16 is a novel scavenger receptor on platelets and is associated with acute coronary syndrome,” Thrombosis and Haemostasis, vol. 105, no. 6, pp. 1112–1114, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. R. Yamauchi, M. Tanaka, N. Kume et al., “Upregulation of SR-PSOX/CXCL16 and recruitment of CD8+ T cells in cardiac valves during inflammatory valvular heart disease,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 24, no. 2, pp. 282–287, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Zivković, T. Djurić, L. Stojković et al., “CXCL16 haplotypes in patients with human carotid atherosclerosis: preliminary results,” Journal of Atherosclerosis and Thrombosis, vol. 22, no. 1, pp. 10–20, 2015. View at Publisher · View at Google Scholar
  10. F. Zhou, J. Wang, K. Wang et al., “Serum CXCL16 as a novel biomarker of coronary artery disease in type 2 diabetes mellitus: a pilot study,” Annals of Clinical and Laboratory Science, vol. 46, no. 2, pp. 184–189, 2016. View at Google Scholar · View at Scopus
  11. L. E. Laugsand, B. O. Åsvold, L. J. Vatten et al., “Soluble CXCL16 and risk of myocardial infarction: The HUNT Study in Norway,” Atherosclerosis, vol. 244, pp. 188–194, 2016. View at Publisher · View at Google Scholar · View at Scopus
  12. D. M. Wuttge, X. Zhou, Y. Sheikine et al., “CXCL16/SR-PSOX is an interferon-γ-regulated chemokine and scavenger receptor expressed in atherosclerotic lesions,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 24, no. 4, pp. 750–755, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Lehrke, S. C. Millington, M. Lefterova et al., “CXCL16 is a marker of inflammation, atherosclerosis, and acute coronary syndromes in humans,” Journal of the American College of Cardiology, vol. 49, no. 4, pp. 442–449, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. J. C. Barrett, B. Fry, J. Maller, and M. J. Daly, “Haploview: analysis and visualization of LD and haplotype maps,” Bioinformatics, vol. 21, no. 2, pp. 263–265, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. Y. Y. Shi and L. He, “SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci,” Cell Research, vol. 15, no. 2, pp. 97–98, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Cheng, M. Cho, J.-M. Cen et al., “A TagSNP in SIRT1 gene confers susceptibility to myocardial infarction in a Chinese Han population,” PLoS ONE, vol. 10, no. 2, Article ID e0115339, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. J. Seiderer, J. Dambacher, D. Leistner et al., “Genotype-phenotype analysis of the CXCL16 p.Ala181Val polymorphism in inflammatory bowel disease,” Clinical Immunology, vol. 127, no. 1, pp. 49–55, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Huang, Y. Han, X. Zhang et al., “An intron polymorphism in the CXCL16 gene is associated with increased risk of coronary artery disease in Chinese Han population: A lArge Angiography-based Study,” Atherosclerosis, vol. 210, no. 1, pp. 160–165, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. J. Tian, S. Hu, F. Wang, X. Yang, Y. Li, and C. Huang, “PPARG, AGTR1, CXCL16 and LGALS2 polymorphisms are correlated with the risk for coronary heart disease,” International Journal of Clinical and Experimental Pathology, vol. 8, no. 3, pp. 3138–3143, 2015. View at Google Scholar · View at Scopus
  20. K. H. Chua, J. G. Ng, C. C. Ng, I. Hilmi, K. L. Goh, and B. P. Kee, “Association of NOD1, CXCL16, STAT6 and TLR4 gene polymorphisms with Malaysian patients with Crohn's disease,” PeerJ, vol. 4, no. 3, article 1843, 2016. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Tatsuguchi, M. Furutani, J.-I. Hinagata et al., “Oxidized LDL receptor gene (OLR1) is associated with the risk of myocardial infarction,” Biochemical and Biophysical Research Communications, vol. 303, no. 1, pp. 247–250, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. Q. Zhang, Y. Du, J. Zhang et al., “Functional impact of 14 single nucleotide polymorphisms causing missense mutations of human α7 nicotinic receptor,” PLoS ONE, vol. 10, no. 9, Article ID e0137588, 2015. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Katoh, “Cancer genomics and genetics of FGFR2 (Review),” International Journal of Oncology, vol. 33, no. 2, pp. 233–237, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. J. Rebehmed, F. Quintus, J.-P. Mornon, and I. Callebaut, “The respective roles of polar/nonpolar binary patterns and amino acid composition in protein regular secondary structures explored exhaustively using hydrophobic cluster analysis,” Proteins: Structure, Function and Bioinformatics, vol. 84, no. 5, pp. 624–638, 2016. View at Publisher · View at Google Scholar · View at Scopus